Brochure | July 28, 2023

Cut The Cost Of Antibody Discovery With A Single Platform

Beacon from Bruker

Cut the time and cost of antibody discovery with the negative pressure Beacon Select™ optofluidic system. This system uses Opto® B Discovery workflows to get you the best antibody lead candidates. By combining massive screening throughput for more shots on goal, function-first assays to funnel to only the best B cells, and high recovery rates of antibody sequences, users can obtain validated antibody sequences against even the hardest targets within 1-2 weeks.

Some of the features and benefits of this system include:

  • Finding antibody sequences against rare targets where others can’t
  • Tailoring your lead candidate discovery to any target and function, including functional blockers and the high-affinity molecules
  • Discovering up to 10-fold more hits, access 50-fold greater sequence diversity, and reduce costs by 20-fold in a matter of days, not weeks
access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online